title: Colistin pharmacokinetics: the fog is lifting.
abstract: Colistin is a re-emerging old antibiotic that is used to treat multidrug-resistant infections in critically ill patients. It corresponds to a mixture of at least 30 different compounds administered as inactive derivatives. Therefore, colistin pharmacokinetics are quite difficult to investigate and complex to predict. However specific chromatographic methods have been made available in recent years, leading to a series of modern pharmacokinetic studies after intravenous administration of the prodrug to critical-care patients; these have been conducted by a few groups and have only been recently published. The objective of this article was to conduct a critical review of these very informative modern pharmacokinetic studies and to provide prospective thoughts.
authors: Inserm ERI-23, CHU, Service de Toxicologie et Pharmacocinétique, UFR Médecine-Pharmacie, Université de Poitiers, Poitiers, France. william.couet@univ-poitiers.fr
authors: W
authors: W
authors: Couet
authors: N
authors: N
authors: Grégoire
authors: S
authors: S
authors: Marchand
authors: O
authors: O
authors: Mimoz
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D003091:Colistin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000187:drug effects; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D006801:Humans; D051381:Rats
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin